19930811
 Schering-Chiron drug for MS to cost patients up to $10,000 yearly   The Wall Street Journal,  Aug 12, 1993  Schering AG told an investor group in New York City that a new drug to quell flare-ups of multiple sclerosis will cost patients between $8,500 and $10,000 a year. Chiron Corp makes the drug, called Betaseron, which will be sold by the Berlex Laboratories unit of Schering.   
